INTERNATIONAL PATENT: HINOVA PHARMACEUTICALS INC., 海创药业股份有限公司 FILES APPLICATION FOR "HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF FOR PREPARING GLP-1 RECEPTOR AGONIST PRODRUG HAVING ORAL PK CHARACTERISTICS AND LONG-ACTING PK CHARACTERISTICS"

Posted On: 2026-04-13

GENEVA, April 13 -- HINOVA PHARMACEUTICALS INC. (No.2-3, 4th Floor, RongYao Tower 1, 5 South Keyuan Road, High-tech ZoneChengdu, Sichuan 610041), 海创药业股份有限公司 (中国四川省成都市高新区科园南路5号蓉药大厦1栋4层附2、3号) filed a patent application (PCT/CN2025/125966) for "HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF FOR PREPARING GLP-1 RECEPTOR AGONIST PRODRUG HAVING ORAL PK CHARACTERISTICS AND LONG-ACTING PK CHARACTERISTICS" on Sep 30, 2025. With publication no. WO/2026/073512, the details related to the pa...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: HINOVA PHARMACEUTICALS INC., 海创药业股份有限公司 FILES APPLICATION FOR "HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF FOR PREPARING GLP-1 RECEPTOR AGONIST PRODRUG HAVING ORAL PK CHARACTERISTICS AND LONG-ACTING PK CHARACTERISTICS"